Jane Street’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.45M | Sell |
9,700
-4,900
| -34% | -$3.14M | ﹤0.01% | 3380 |
|
|
2025
Q4 | $9.88M | Sell |
14,600
-27,200
| -65% | -$18.5M | ﹤0.01% | 2334 |
|
|
2025
Q3 | $26.7M | Buy |
41,800
+20,000
| +92% | +$12.1M | ﹤0.01% | 1398 |
|
|
2025
Q2 | $11.7M | Buy |
21,800
+8,400
| +63% | +$4.02M | ﹤0.01% | 1962 |
|
|
2025
Q1 | $5.63M | Buy |
13,400
+4,300
| +47% | +$1.87M | ﹤0.01% | 2763 |
|
|
2024
Q4 | $3.76M | Sell |
9,100
-5,400
| -37% | -$2.37M | ﹤0.01% | 3075 |
|
|
2024
Q3 | $7.33M | Buy |
14,500
+4,900
| +51% | +$2.38M | ﹤0.01% | 2298 |
|
|
2024
Q2 | $4.68M | Sell |
9,600
-2,500
| -21% | -$1.26M | ﹤0.01% | 3061 |
|
|
2024
Q1 | $6.53M | Sell |
12,100
-500
| -4% | -$273K | ﹤0.01% | 2266 |
|
|
2023
Q4 | $6.99M | Buy |
12,600
+3,000
| +31% | +$1.41M | ﹤0.01% | 2391 |
|
|
2023
Q3 | $4.2M | Sell |
9,600
-5,700
| -37% | -$2.84M | ﹤0.01% | 2867 |
|
|
2023
Q2 | $7.68M | Sell |
15,300
-5,600
| -27% | -$2.68M | ﹤0.01% | 2203 |
|
|
2023
Q1 | $10.5M | Sell |
20,900
-11,200
| -35% | -$5.36M | ﹤0.01% | 1593 |
|
|
2022
Q4 | $13.1M | Buy |
32,100
+10,900
| +51% | +$4.23M | 0.01% | 1354 |
|
|
2022
Q3 | $6.91M | Sell |
21,200
-26,400
| -55% | -$9.7M | ﹤0.01% | 2150 |
|
|
2022
Q2 | $16.7M | Buy |
47,600
+23,500
| +98% | +$9.58M | 0.01% | 1260 |
|
|
2022
Q1 | $13.2M | Buy |
24,100
+4,900
| +26% | +$2.58M | ﹤0.01% | 1655 |
|
|
2021
Q4 | $12.6M | Sell |
19,200
-39,200
| -67% | -$24.6M | ﹤0.01% | 1622 |
|
|
2021
Q3 | $36.3M | Sell |
58,400
-8,700
| -13% | -$5.85M | 0.01% | 747 |
|
|
2021
Q2 | $42.4M | Buy |
67,100
+52,300
| +353% | +$28.9M | 0.02% | 632 |
|
|
2021
Q1 | $7.24M | Sell |
14,800
-600
| -4% | -$301K | ﹤0.01% | 1913 |
|
|
2020
Q4 | $7.7M | Buy |
15,400
+9,900
| +180% | +$4.43M | ﹤0.01% | 1648 |
|
|
2020
Q3 | $2.16M | Sell |
5,500
-4,800
| -47% | -$1.77M | ﹤0.01% | 2913 |
|
|
2020
Q2 | $3.4M | Buy |
10,300
+6,600
| +178% | +$1.91M | ﹤0.01% | 2334 |
|
|
2020
Q1 | $896K | Buy |
+3,700
| New | +$966K | ﹤0.01% | 2923 |
|
|
2019
Q4 | – | Sell |
-2,800
| Closed | -$761K | – | 5369 |
|
|
2019
Q3 | $761K | Buy |
2,800
+1,600
| +133% | +$445K | ﹤0.01% | 2968 |
|
|
2019
Q2 | $330K | Buy |
1,200
+300
| +33% | +$73.9K | ﹤0.01% | 4076 |
|
|
2019
Q1 | $201K | Buy |
+900
| New | +$186K | ﹤0.01% | 4651 |
|
|
2018
Q3 | – | Sell |
-1,100
| Closed | -$240K | – | 5376 |
|
|
2018
Q2 | $240K | Buy |
+1,100
| New | +$227K | ﹤0.01% | 4358 |
|
Other funds holding IDXX
VCM
VPM
Jane Street's IDXX Position: Q1 2026 in Review
Jane Street increased its Idexx Laboratories (IDXX) stake by 66% in Q1 2026, buying an estimated $3.84M and bringing the position to 14,998 shares worth $8.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2755.
Jane Street first reported a position in IDXX in Q2 2013 and has held it in 45 quarters since. The position peaked at $22.5M in Q2 2022. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Jane Street held 14,998 shares of Idexx Laboratories worth $8.43M as of Q1 2026.
- Jane Street bought 5,984 Idexx Laboratories shares in Q1 2026, an estimated $3.84M.
- Idexx Laboratories made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2755 holding.
- Jane Street first reported a position in Idexx Laboratories in Q2 2013 and has held it in 45 quarters since.
- Jane Street's Idexx Laboratories position peaked at $22.5M in Q2 2022.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.